» Articles » PMID: 30675422

Reducing Major Risk Factors for Chronic Kidney Disease

Abstract

Chronic kidney disease (CKD) is a global public health concern and a key determinant of poor health outcomes. While the burden of CKD is reasonably well defined in developed countries, increasing evidence indicates that the CKD burden may be even greater in developing countries. Diabetes, hypertension, and obesity are major contributors to the global burden of the disease and are important CKD risk factors; however, CKD risk factors such as nephrotoxin exposure, kidney stones, fetal and maternal factors, infections, environmental factors, and acute kidney injury are also increasingly being recognized as major threats to global kidney health. A broad approach to CKD prevention begins with the identification of CKD risk factors in the population, followed by the development of appropriate mitigation strategies. Effective prevention policies rely on an accurate understanding of the incidence and prevalence of CKD in a given setting, as well as the distribution and burden of risk factors. Populations or individuals at CKD risk must be screened and treated early to prevent the onset of and delay the progression of the kidney disease. Systematically collected data should be analyzed at country, province, and district levels to identify regional disparities and CKD hotspots and develop targeted prevention strategies. Race-ethnicity, genetics, sex, socioeconomic status, and geography are likely modifiers of CKD risk. A comprehensive, informed approach to prevention that takes into account all of these factors is therefore required to successfully tackle the global CKD epidemic.

Citing Articles

Prevalence and Factors Associated with Kidney Stones in the Elderly Iranian Population: Findings from the Ardakan Cohort Study on Aging (ACSA).

Delbari A, Farrokhi M, Mehri A, Saberian M, Sadri M, Saatchi M Arch Iran Med. 2025; 28(2):73-80.

PMID: 40062494 PMC: 11892097. DOI: 10.34172/aim.33337.


Ambient Air Pollution and Chronic kidney disease risk in Deltan communities: A Policy Brief, 2023.

Okoye O, Carnegie E, Mora L F1000Res. 2025; 13:265.

PMID: 39895946 PMC: 11783039. DOI: 10.12688/f1000research.145904.2.


Prevalence of chronic kidney disease and associated factors among adult diabetic patients: a hospital-based cross-sectional study.

Aregawi K, Kabew Mekonnen G, Belete R, Kucha W Front Epidemiol. 2024; 4:1467911.

PMID: 39628978 PMC: 11611590. DOI: 10.3389/fepid.2024.1467911.


Higher prevalence of kidney function impairment among older people living with HIV in Uganda.

Ssemasaazi A, Kalyesubula R, Manabe Y, Mbabazi P, Naikooba S, Ssekindi F BMC Nephrol. 2024; 25(1):321.

PMID: 39334034 PMC: 11428404. DOI: 10.1186/s12882-024-03761-1.


Prevalence of and factors associated with chronic kidney disease among patients infected with human immunodeficiency virus attending care and treatment centers at tertiary hospitals in dodoma, Tanzania.

Mwise M, Magoma S, Meremo A Heliyon. 2024; 10(12):e32994.

PMID: 38988569 PMC: 11234037. DOI: 10.1016/j.heliyon.2024.e32994.


References
1.
Strazzullo P, Barba G, Vuotto P, Farinaro E, Siani A, Nunziata V . Past history of nephrolithiasis and incidence of hypertension in men: a reappraisal based on the results of the Olivetti Prospective Heart Study. Nephrol Dial Transplant. 2001; 16(11):2232-5. DOI: 10.1093/ndt/16.11.2232. View

2.
Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U . Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002; 346(2):77-84. DOI: 10.1056/NEJMoa010369. View

3.
Adler A, Stevens R, Manley S, Bilous R, Cull C, Holman R . Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 2002; 63(1):225-32. DOI: 10.1046/j.1523-1755.2003.00712.x. View

4.
Barsoum R . End-stage renal disease in North Africa. Kidney Int Suppl. 2003; (83):S111-4. DOI: 10.1046/j.1523-1755.63.s83.23.x. View

5.
Taylor E, Stampfer M, Curhan G . Obesity, weight gain, and the risk of kidney stones. JAMA. 2005; 293(4):455-62. DOI: 10.1001/jama.293.4.455. View